1 unchanged sentence
Rule 10b5-1 Trading Plans
−Removed: On August 12, 2024 , Robert Marshall , our CFO and Treasurer , entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, providing for the potential sale of up to 20,000 shares of our common stock between November 15, 2024 and March 17, 2025 .
+Added: On February 28, 2025 , Paul Blanchfield , our President , entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a “10b5-1 Plan”).
+Added: The 10b5-1 Plan provides for the potential sale of up to 29,271 shares of our common stock between June 5, 2025, and March 6, 2026 .
+Added: Pursuant to the 10b5-1 Plan, Mr.
+Added: Blanchfield will also make a gift of 659 shares of common stock on November 14, 2025.
+Added: On March 3, 2025 , Mary Anne Heino , the Chairperson of our Board , entered into a 10b5-1 Plan providing for the potential sale of shares of our common stock in an amount necessary to attain approximately net sale proceeds of $2,000,000 between June 2, 2025,
+Added: and June 13, 2025 .
+Added: The 10b5-1 Plan also provides for the potential sale of up to 70,142 shares of our common stock between August 8, 2025, and March 13, 2026.
+Added: On March 6, 2025 , Daniel Niedzwiecki , our Chief Administrative Officer, General Counsel and Corporate Secretary , entered into a 10b5-1 Plan providing for the potential sale of up to 12,000 shares of our common stock between June 5, 2025, and July 7, 2025 .
+Added: On March 10, 2025 , Julie McHugh , a member of our Board , entered into a 10b5-1 Plan providing for the potential sale of up to 5,192 shares of our common stock on June 9, 2025 .
+Added: On March 11, 2025 , Samuel R.
+Added: Leno , a member of our Board , entered into a 10b5-1 Plan providing for the potential sale of up to 14,307 shares of our common stock between June 11, 2025, and November 12, 2025 .
+Added: On March 11, 2025 , Robert Marshall , our CFO and Treasurer , entered into a 10b5-1 Plan providing for the potential sale of up to 39,773 shares of our common stock between June 9, 2025, and June 30, 2025 .
INCORPORATED BY REFERENCE
1 unchanged sentence
NUMBER EXHIBIT FILING
−Removed: 10.1*+ Eighth Amendment to Lantheus Holdings, Inc.
−Removed: 2015 Equity Incentive Plan
+Added: Third Amendment to Lease dated as of February 14, 2025, by and between Lantheus Medical and 201 Burlington Road Owner, LLC
31.1* Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a).
11 unchanged sentences
** Furnished herewith.
−Removed: + Indicates management contract or compensatory plan or arrangement.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
4 unchanged sentences
(Principal Executive Officer)
−Removed: November 6, 2024
LANTHEUS HOLDINGS, INC.
4 unchanged sentences
(Principal Financial Officer)
−Removed: November 6, 2024
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.